Article thumbnail

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications

By J. Alexandra Rowe, Antoine Claessens, Ruth A. Corrigan and Mònica Arman

Abstract

Severe malaria has a high mortality rate (15–20%) despite treatment with effective antimalarial drugs. Adjunctive therapies for severe malaria that target the underlying disease process are therefore urgently required. Adhesion of erythrocytes infected with Plasmodium falciparum to human cells has a key role in the pathogenesis of life-threatening malaria and could be targeted with antiadhesion therapy. Parasite adhesion interactions include binding to endothelial cells (cytoadherence), rosetting with uninfected erythrocytes and platelet-mediated clumping of infected erythrocytes. Recent research has started to define the molecular mechanisms of parasite adhesion, and antiadhesion therapies are being explored. However, many fundamental questions regarding the role of parasite adhesion in severe malaria remain unanswered. There is strong evidence that rosetting contributes to severe malaria in sub-Saharan Africa; however, the identity of other parasite adhesion phenotypes that are implicated in disease pathogenesis remains unclear. In addition, the possibility of geographic variation in adhesion phenotypes causing severe malaria, linked to differences in malaria transmission levels and host immunity, has been neglected. Further research is needed to realise the untapped potential of antiadhesion adjunctive therapies, which could revolutionise the treatment of severe malaria and reduce the high mortality rate of the disease

Topics: Review Article
Publisher: Cambridge University Press
OAI identifier: oai:pubmedcentral.nih.gov:2878476
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (1989). A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes.
  2. (2002). A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria.
  3. (1998). A recombinant peptide based on PfEMP-1 blocks and reverses adhesion of malaria-infected red blood cells to CD36 under flow.
  4. (2005). Artesunate versus quininefortreatmentofseverefalciparummalaria: a randomised trial.
  5. (1996). Biochemical Parasitology 144, 109-113 121 Vigan-Womas,I.etal.(2008)Aninvivoandinvitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.
  6. (1999). CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes.
  7. (1991). Clinical correlates of in vitro Plasmodium falciparum cytoadherence.
  8. (2001). CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand.
  9. (2005). Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria.
  10. (2007). Dissection of the role of PfEMP1 and ICAM-1 in the sensing of Plasmodium falciparum-infected erythrocytes by natural killer cells.
  11. (2008). Does activation of the blood coagulation cascade have a role in malaria pathogenesis? Trends in
  12. (2007). Effects of malaria heme products on red blood cell deformability.
  13. (1990). Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies.
  14. (1992). Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1.
  15. (2008). Identification of residues intheCmu4domainofpolymericIgMessentialfor interactionwithPlasmodiumfalciparumerythrocyte membrane protein 1 (PfEMP1).
  16. (2007). Intravascular infiltrates and organ-specific inflammation in malaria pathogenesis.
  17. (1994). Lactic acidosis and hypoglycaemia in children with severe malaria: pathophysiological and prognostic significance.
  18. (2006). Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence.
  19. (1992). Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction and transfusion medicine.
  20. (1994). Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation.
  21. (2000). Nonopsonic monocyte/macrophage phagocytosis of Plasmodium falciparum-parasitized erythrocytes: a role for CD36 in malarial clearance.
  22. (2008). Plasmodium falciparum STEVOR proteins are highly expressed in patient isolates and located in the surface membranes of infected red blood cells and the apical tips of merozoites.
  23. (1994). Plasmodium falciparum:a family of sulphated glycoconjugates disrupts erythrocyterosettes.ExperimentalParasitology79, 506-516 192 Rogerson,S.J.etal.(1994)Sulfatedglycoconjugates as disrupters of Plasmodium falciparum erythrocyte rosettes.
  24. (2003). Platelet accumulation in brain microvessels in fatal pediatric cerebral malaria.JournalofInfectiousDiseases187,461-466 140
  25. (1992). Rapid switching to multiple antigenic and adhesive phenotypes in malaria.
  26. (1999). Red cell selectivity in malaria: a study of multiple-infected erythrocytes.
  27. (1991). Rosette formation of Plasmodium falciparum-infected erythrocytes from patients with acute malaria.
  28. (2004). shuman microvascular endothelial cells.
  29. Soluble human complement receptor type I: In vivo inhibitor of complement suppressing post-ischaemic myocardial inflammation and necrosis.
  30. (2008). spostmortem parasite counts.
  31. (2008). sregion for binding of the Plasmodium falciparum variant antigen to ICAM-1. Molecular and Biochemical Parasitology 137, 55-64 82
  32. (1992). The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site.
  33. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217 2 Marsh,K.etal.(1995)Indicatorsoflife-threatening malaria in African children. New England
  34. (2007). The importance of human FcgammaRI in mediating protection to malaria. PLoS
  35. (1998). The roleofrosettinginthemultiplicationofPlasmodium falciparum: rosette formation neither enhances nor targets parasite invasion into uninfected red cells.
  36. (2003). The war between the malaria parasite and the immune system: immunity, immunoregulation and immunopathology.
  37. Transactions of the Royal Society of Tropical Medicine and Hygiene 88, 67-73 205 Rowe,J.A.etal.(2002)Positivecorrelationbetween rosettingandparasitemiainPlasmodiumfalciparum clinical isolates.